Co-Founder, President And Ceo
CurrentAfter working in the molecular glue field of drug discovery for roughly a decade, I took the chance to co-found a company specializing in this approach. Molecular glue drugs can trigger the degradation of proteins in ways that don't conform to the rules of other drug modalities, enabling them to be used to tackle 'undruggable' proteins linked to disease..